BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21294926)

  • 1. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.
    Gao L; Yan L; Lin B; Gao J; Liang X; Wang Y; Liu J; Zhang S; Iwamori M
    J Exp Clin Cancer Res; 2011 Feb; 30(1):15. PubMed ID: 21294926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.
    Li F; Lin B; Hao Y; Li Y; Liu J; Cong J; Zhu L; Liu Q; Zhang S
    Int J Mol Sci; 2010 Sep; 11(10):3748-59. PubMed ID: 21152298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells.
    Gao S; Liu Q; Wang X; Lin B; Zhang S
    Med Oncol; 2010 Sep; 27(3):960-7. PubMed ID: 19771531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
    Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
    J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin alpha5beta1 with the Lewis Y-structure on transfection of the alpha1,2-fucosyltransferase gene.
    Yan LM; Lin B; Zhu LC; Hao YY; Qi Y; Wang CZ; Gao S; Liu SC; Zhang SL; Iwamori M
    Biochimie; 2010 Jul; 92(7):852-7. PubMed ID: 20172014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
    Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Lewis y antigen on regulating gene expression of partial drug resistance associated proteins in human ovarian cancer cell line RMG-I-H].
    Liu Q; Lin B; Wang PL; Yan LM; Hao YY; Li FF; Zhu LC; Zhang SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Aug; 31(4):481-7. PubMed ID: 19771739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of anti-Lewis y antibody on alpha1,2-fucosyltransferase gene transfected human ovarian cancer cells in vitro].
    Li FF; Lin B; Hao YY; Liu JJ; Zhang F; Zhang SL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):267-9. PubMed ID: 18328190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.
    Yan L; Lin B; Gao L; Gao S; Liu C; Wang C; Wang Y; Zhang S; Iwamori M
    Int J Mol Sci; 2010 Nov; 11(11):4441-52. PubMed ID: 21151448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfection of alpha1, 2-fucosyltransferase gene increases the antigenic expression of Lewis y in ovarian cancer cell line RMG-I].
    Lin B; Hao YY; Wang DD; Zhu LC; Zhang SL; Saito M; Iwamori M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):284-9. PubMed ID: 18686606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways.
    Liu D; Liu J; Lin B; Liu S; Hou R; Hao Y; Liu Q; Zhang S; Iwamori M
    Int J Mol Sci; 2012; 13(1):828-839. PubMed ID: 22312289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.
    Li FF; Liu JJ; Liu DW; Lin B; Hao YY; Cong JP; Zhu LC; Gao S; Zhang SL; Iwamori M
    Int J Oncol; 2012 Apr; 40(4):1196-202. PubMed ID: 22179544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
    Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
    PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
    Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β.
    Wang C; Yan L; Wang Y; Lin B; Liu S; Li Q; Gao L; Zhang S; Iwamori M
    Anat Rec (Hoboken); 2011 Jun; 294(6):961-9. PubMed ID: 21542140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.
    Catterall JB; Jones LM; Turner GA
    Clin Exp Metastasis; 1999; 17(7):583-91. PubMed ID: 10845557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
    Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
    J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers.
    Hu Z; Gao J; Zhang D; Liu Q; Yan L; Gao L; Liu J; Liu D; Zhang S; Lin B
    PLoS One; 2013; 8(2):e57250. PubMed ID: 23468946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.
    Yan L; Wang C; Lin B; Liu J; Liu D; Hou R; Wang Y; Gao L; Zhang S; Iwamori M
    Biochimie; 2015 Jun; 113():17-25. PubMed ID: 25726913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.